Codes / ICD10CM / T78.01XS

T78.01XS Anaphylactic reaction due to peanuts, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Anaphylactic reaction due to peanuts, sequela (ICD-10 Code: T78.01XS)

Summary

This code is used to document the residual effects of an anaphylactic reaction due to peanuts. Sequela refers to the late effects or complications that persist after the acute phase of the condition has resolved. The code applies when the patient experiences ongoing health issues directly attributable to a prior anaphylactic reaction triggered by peanuts.

Causes

Sequela of an anaphylactic reaction due to peanuts result from the initial severe allergic response. The immune system's overreaction to peanut proteins can cause lasting damage to tissues or organs, leading to chronic symptoms. These effects may include persistent respiratory issues, neurological changes, or other systemic complications that develop after the acute event.

Risk Factors

  • History of severe peanut anaphylaxis
  • Delayed or inadequate treatment of the initial reaction
  • Underlying chronic conditions (e.g., asthma, cardiovascular disease)
  • Repeated exposure to peanuts or peanut allergens
  • Genetic predisposition to severe allergic reactions

Symptoms

  • Chronic respiratory problems (e.g., persistent wheezing, shortness of breath)
  • Neurological symptoms (e.g., memory issues, mood changes)
  • Gastrointestinal disturbances (e.g., ongoing abdominal pain)
  • Fatigue or reduced exercise tolerance
  • Psychological effects (e.g., anxiety related to food exposure)

Diagnosis

Diagnosis is based on clinical evaluation of persistent symptoms and correlation with a documented prior anaphylactic event due to peanuts. Healthcare providers assess the timeline of symptom onset, exclude other causes, and confirm the link to the initial reaction. Imaging or functional tests may be used to identify specific residual effects.

Treatment Options

Management focuses on addressing the specific sequela and preventing future reactions. This may include:

  • Long-term medications for respiratory or gastrointestinal symptoms
  • Referral to specialists (e.g., pulmonology, neurology)
  • Allergen avoidance education
  • Psychological support for anxiety or trauma
  • Regular monitoring for new or worsening symptoms

Prognosis and Follow-Up

Prognosis varies depending on the severity of the initial reaction and the nature of the sequela. Some patients may experience gradual improvement, while others may have permanent effects. Follow-up care is essential to monitor for complications, adjust treatments, and ensure ongoing allergen avoidance. Regular check-ins with healthcare providers help manage long-term health.

Complications

  • Chronic respiratory impairment (e.g., asthma, reduced lung function)
  • Neurological deficits (e.g., cognitive changes, mood disorders)
  • Gastrointestinal disorders (e.g., irritable bowel syndrome)
  • Increased risk of future anaphylactic reactions
  • Psychological impact (e.g., food-related anxiety, PTSD)

Lifestyle & Prevention

  • Strict avoidance of peanuts and peanut-containing products
  • Reading food labels carefully and asking about ingredients in restaurants
  • Carrying emergency medications (e.g., epinephrine auto-injector)
  • Wearing medical identification (e.g., bracelet) indicating peanut allergy
  • Educating family, friends, and caregivers about the allergy

When to Seek Professional Help

Seek immediate medical attention if:

  • New or worsening symptoms (e.g., difficulty breathing, swelling) occur
  • There is uncertainty about symptom causes or management
  • Psychological distress (e.g., severe anxiety) impacts daily life
  • Follow-up care is needed to adjust treatment plans

Tips for Medical Coders

This code is a sequela code and should only be used when the patient has a history of anaphylactic reaction due to peanuts and is experiencing residual effects. Documentation must clearly link the current symptoms to the prior event. Ensure the "XS" modifier is appropriate for the encounter type (e.g., subsequent encounter). Verify that the sequela is directly attributable to the initial reaction and not a new, unrelated condition.

Book a walkthrough

T78.01XS policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.